Robert Kamen serves as Executive at Jounce Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert Kamen has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 3, 2023 involved transacting 33,875 shares valued at $0.
Robert Kamen currently holds 0 shares of Jounce Therapeutics, Inc. (JNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Kamen has been a net neutral trader of JNCE stock. They have purchased $0 and sold $0 worth of shares.
Robert Kamen's most recent insider trade was on May 3, 2023, when they sold 33,875 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |